Funding for this research was provided by:
United States Department of Defense | Defense Advanced Research Projects Agency (HR0011-17-2-0049)
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (RM1 HG009490)
U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering (R01 EB022376)
U.S. Department of Health & Human Services | NIH | NIH Office of the Director (U01 AI142756)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R35 GM118062)
Howard Hughes Medical Institute (Liu investigatorship)
Article History
Received: 26 September 2018
Accepted: 23 May 2019
First Online: 2 July 2019
Competing interests
: The authors have filed a patent application on protein delivery technologies. The patent applicant is the Broad Institute and Harvard University with Y.B.K., K.T.Z. and D.R.L. as the named inventors. This patent is in regards to the use of ProTa for protein delivery. D.R.L. is a co-founder and consultant of Editas Medicine, Beam Therapeutics, and Pariwise Plants, companies that use genome editing. The remaining authors declare no competing interests.